Please login to the form below

Not currently logged in
Email:
Password:

Healthwatch England names Katherine Rake as director

Former advisor to Prime Minister will lead body to give patients in England a say in health policy

Katherine Rake, Healthwatch EnglandDr Katherine Rake has joined recently-launched patient body Healthwatch England as its director.

She has a strong pedigree in health and social policy in the UK, where her most recent roles were as chief executive of the Family and Parenting Institute and advisor to the Prime Minister.

This experience will be valuable as she leads the organisation, created as part of wholesale NHS reforms, that aims to give patients and the general public a voice in the way health and social care services are run in the country.

"I am delighted to have been appointed as the first director of Healthwatch England at a critical time of transition for health and social care in the UK,” said Dr Rake.

“I look forward to ensuring that the views of health and social care consumers are heard at the highest levels and the insight gained is used to transform delivery of these services for the better."

Prior to her most recent role, Dr Rake served as chief executive of sexual equality campaign group the Fawcett Society. She has also spent time as a lecturer in social policy at the London School of Economics.

Her appointment was announced the same day as Healthwatch England's first public meeting, during which the committee discussed where the body should focus its energy and resources.

Part of its responsibility involves overseeing local Healthwatch groups, of which more than 150 are planned to be formed during 2013. These local groups will be commissioned by, and fully accountable to, their local authority and will replace the Local Involvement Network (LINks).

6th December 2012

From: Healthcare

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Parkinson’s disease: past, present and future
Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...